Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Affimed Therapeutics
Biotech
BMS vet answers Foghorn’s call for CBO—Chutes & Ladders
BMS vet answers Foghorn’s call for CBO. Orbital charges up with former Spark CEO. CellCentric secures first CDO.
Darren Incorvaia
,
Zoey Becker
,
Gabrielle Masson
Sep 6, 2024 8:30am
Ex-Celgene CEO takes the top job at TORL—Chutes & Ladders
Jan 12, 2024 9:30am
Affimed stops enrolling multiple tumor types as data disappoint
Dec 11, 2023 9:10am
FDA promotes Bumpus to replace Woodcock—Chutes & Ladders
Dec 1, 2023 9:48am
ASCO: Affimed pivots to cancer combo as monotherapy falls short
Jun 5, 2023 6:27am
Affimed reveals 25% of staff were let go in April
May 23, 2023 9:01am